
CoDx supports biotechnology and medical diagnostics stakeholders in their strategic, scientific, and partnership challenges. We work at different development stages, from proof of concept to post-R&D valorization and transfer to production.
Our service offering is built around 4 key competencies:
Strategic & business consulting
We provide tailored support to healthcare project leaders in structuring their business model, defining a clear roadmap, establishing functional specifications including marketing and client requirements, and preparing strategic documents for investors or institutional partners.
Market positioning analysis, SWOT analysis, and definition of the product's unique selling proposition
Pitch deck & fundraising
Strategic roadmap
Business plan and P&L preparation
Scientific audits of companies (SMEs)


Diagnostics & biomarkers
CoDx's founder brings deep expertise in biomarker development, proof-of-concept (PoC) studies, and pre-analytical and analytical validation for personalised medicine projects, including companion diagnostics, and more broadly across medical diagnostics.
Biomarker development consulting, from PoC to industrial transfer
Analytical validation and clinical verification studies for new biomarkers
Literature reviews for investors and positioning of new markers
Partnerships & ecosystem
We help the integration of client's projects into a coherent ecosystem by leveraging our networks of experts, institutions, KOLs and investors. Our goal: strengthening the legitimacy, reach and sustainability of the initiatives we support for optimal client's satisfaction.
Support for grant applications, particularly European Commission programmes (HE, IHI, EIC, etc.)
Access to our networks of key opinion leaders (KOLs) and experts, including IVD and MDR regulatory specialists, with targeted introductions
Access to biobank networks for samples from healthy subjects and patients (plasma, serum, stool, tissue and more)


Licensing & technology transfer
We support project leaders in maximising the value of their innovations through licensing agreements, technology transfers and strategic partnerships between laboratories, universities and industry players.
Support in securing licences and patent access (licensing-in and licensing-out)
Intellectual property and freedom-to-operate (FTO) advice
R&D results valorisation
Academia-industry bridging
Agreement structuring
















